<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02439151</url>
  </required_header>
  <id_info>
    <org_study_id>2014-KE-143</org_study_id>
    <nct_id>NCT02439151</nct_id>
  </id_info>
  <brief_title>Applied Research of New Lung Ventilation Strategies Guided by Transpulmonary Pressure in Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rui Wang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extracorporeal membrane oxygenation (ECMO) has been widely used in patients with severe acute
      respiratory distress syndrome (ARDS). But how to choose mechanical ventilation strategy is
      still not clear for severe ARDS patients supported by ECMO. Our previous work found that,
      compared to the traditional &quot;lung rest&quot; strategy, transpulmonary pressure guide new lung
      ventilation strategy can better maintain lung volume reduction lung collapse, atelectasis
      occurs. The severe ARDS patients receiving ECMO therapy were randomized divided into a new
      ventilation strategy group and the conventional ventilation strategy group. The new
      ventilation strategy is transpulmonary pressure guide ventilator setting method, and the
      conventional ventilation strategy is Extracorporeal Life Support Organization (ELSO) guide
      ventilation method. Compare the difference between the two groups of patients in lung injury,
      and explore the lung protection mechanism of new lung ventilation strategies guided by
      transpulmonary pressure. Our research group considered that transpulmonary pressure guide new
      lung ventilation strategy can provide more effective lung protection. And it will be further
      used in clinical work.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successfully weaned from ECMO</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death in ICU</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Respiratory Distress Syndrome, Adult</condition>
  <arm_group>
    <arm_group_label>New Strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>New Strategy: use transpulmonary pressure guide new lung ventilation strategy in ECMO for severe ARDS patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Strategy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conventional Strategy: use conventional ventilation strategy (ELSO guide ventilation strategy) in ECMO for severe ARDS patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>New lung ventilation strategy</intervention_name>
    <description>New ventilation strateg: PCV molel; FiO2 0.3; regulate the PC allows transpulmonary pressure at the end of inspiration less than 20cmH2O; Ti 1s; frequency 10bpm; regulate the PEEP allows transpulmonary pressure at the end of expiration greater than 0cmH2O and less than 5cmH2O.</description>
    <arm_group_label>New Strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional ventilation strategy</intervention_name>
    <description>Conventional ventilation strategy: PCV molel; FiO2 0.3; PC 10cmH2O; Ti 1s; frequency 10bpm; PEEP 10cmH2O.</description>
    <arm_group_label>Conventional Strategy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ARDS cause reversible;

          -  Pure oxygen is given, but PaO2/FiO2＜100;

          -  P(A-a)O2＞600mmHg;

          -  Murray score≥3.0;

          -  pH＜7.2;

        Exclusion Criteria:

          -  peak inspiratory pressure＞30cmH2O;

          -  high FiO2＞0.8;

          -  ventilation＞7 days;

          -  contraindication to heparinization;

          -  non-reversible central nervous system injury

          -  chronic disease with a short life expectancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2015</study_first_submitted>
  <study_first_submitted_qc>May 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2015</study_first_posted>
  <last_update_submitted>May 6, 2015</last_update_submitted>
  <last_update_submitted_qc>May 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Rui Wang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Extracorporeal Membrane Oxygenation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

